Tất cả các loại
| Product Name | Mô tả | Action |
|---|---|---|
| Sacituzumab govitecan, Trodelvy, TROP-2, IMMU-132, ADC ung thư / ADC ung thư vú bộ ba âm tính / ADC ung thư biểu mô đường tiết niệu, Số CAS.1491917-83-9 | Trade Name : Trodelvy Target : TROP-2 Molecular Type : ADC Sales in 2025 (Millions of USD) : 1014(First three quarters) All detailed product information shall be subject to the issued final COA. Should you need further in-depth documentation for this item, kindly get in touch with us. |
|
| Risankizumab, Skyrizi, Bisepcific antibody, BI 655066, Interleukin inhibitor / IL-23 inhibitor, Immunology biologic, Monoclonal antibody, CAS No. 1612838-76-2 | Trade Name : Skyrizi Target : Bispecific antibody Molecular Type : Monoclonal Antibody Sales in 2025 (Millions of USD) : 13000~15000(estimate) All detailed product information shall be subject to the issued final COA. Should you need further in-depth documentation for this item, kindly get in touch ... |
|
| Tezepelumab, Tesspire, TSLP, Monoclonal Antibody, AMG 157, Biological Anti-TSLP, Biological Respiratory / Asthma, CAS No. 1572943-60-0 | Trade Name : Tezspire Target : TSLP Molecular Type : Monoclonal Antibody Sales in 2025 (Millions of USD) : 826(First half of the year) All detailed product information shall be subject to the issued final COA. Should you need further in-depth documentation for this item, kindly get in touch with us. |
|
| Dupilumab,Dupixent,REGN668,Inhibitor Interleukin receptor, Immunology biologic, Monoclonal Antibody, CAS No.1190264-60-8 | Trade Name : Dupixent Target : N/A Molecular Type : Monoclonal Antibody Sales in 2025 (Millions of USD) : 1340(First three quarters) All detailed product information shall be subject to the issued final COA. Should you need further in-depth documentation for this item, kindly get in touch with us. |
|
| Hyaluronidase, Enzyme / Recombinant enzyme, Biological excipient / Biological co-formulation component, CAS số 9001-54-1 | Trade Name : N/A Target : N/A Molecular Type : Enzymes Sales in 2025 (Millions of USD) : 1300~1375(estimate) All detailed product information shall be subject to the issued final COA. Should you need further in-depth documentation for this item, kindly get in touch with us. |
|
| Etanercept | Trade Name : Enbrel Target : N/A Molecular Type : Fusion Protein Sales in 2025 (Millions of USD) : 2300~2500(estimate) All detailed product information shall be subject to the issued final COA. Should you need further in-depth documentation for this item, kindly get in touch with us. |
|
| Pertuzumab, Perjeta, Phesgo, 2C4, Liệu pháp nhắm mục tiêu chống HER2, Kháng thể sinh học ung thư / ung thư vú, Kháng thể đơn bào, CAS số 380610-27-5 | Trade Name : Perjeta Target : N/A Molecular Type : Monoclonal Antibody Sales in 2025 (Millions of USD) : 2800(First three quartersestimate ) All detailed product information shall be subject to the issued final COA. Should you need further in-depth documentation for this item, kindly get in touch ... |
|
| Tocilizumab | Trade Name : Actemra Target : N/A Molecular Type : Monoclonal Antibody Sales in 2025 (Millions of USD) : 1280(First half of the year) All detailed product information shall be subject to the issued final COA. Should you need further in-depth documentation for this item, kindly get in touch with us. |
